Thrombin reduces large heparan sulfate proteoglycan molecules in cultured vascular endothelial cell layers through inhibition of core protein synthesis

Thrombosis Research

Volumn 88, Issue 3, 1997, Pages 299-307

  Fujii, Noriyasu ^a   Kaji, Toshiyuki ^a   Akai, Takuya ^b   Koizumi, Fumitomo ^c  

^a HOKURIKU UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Heparan sulfate; Proteoglycan; Thrombin; Vascular endothelial cell

Indexed keywords

CORE PROTEIN; HEPARAN SULFATE; PROTEOGLYCAN; THROMBIN;

ANIMAL CELL; ARTICLE; CATTLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GEL FILTRATION; ION EXCHANGE CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; VASCULAR ENDOTHELIUM;

ANIMALS; CATTLE; CELLS, CULTURED; CHROMATOGRAPHY; ENDOTHELIUM, VASCULAR; HEPARAN SULFATE PROTEOGLYCANS; PROTEIN PRECURSORS; THROMBIN;

EID: 0031278018     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00257-0     Document Type: Article

References (33)

1. Maynard JR, Dreyer BE, Stemerman MB, Pitlick FA. Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblast. Blood 1977;50:387-96.
2. Van Mourik JA, Lawrence DA, Loskutoff DJ. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. J Biol Chem 1984;259:14914-21.
3. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
4. Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein. C Proc Natl Acad Sci USA 1981;78:2249-52.
5. Levin EG, Loskutoff DJ. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J Cell Biol 1982;94:631-6.
6. 2 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci USA 1977;74:3922-6.
7. Gamse G, Fromme HG, Kresse H. Metabolism of sulfated glycosaminoglycans in cultured endothelial cells and smooth muscle cells from bovine aorta. Biochem Biophys Acta 1978;544:514-28.
8. Nader HB, Dietrich CP, Buonassisi V. and Colburn, P. Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan. Proc Natl Acad Sci USA 1987;84:3565-9.
9. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitis DM. Cell surface heparin-like molecules are required for binding of bFGF to its high affinity receptor. Cell 1991;64:841-8.
10. Kaji T, Hiraga S, Ohkawara S, Inada M, Yamamoto C, Kozuka H, Koizumi F. Regulation by basic fibroblast growth factor of glycosaminoglycan biosynthesis in cultured vascular endothelial cells. Microvasc Res 1995;49:268-76.
11. Kobayashi M, Shimada K, Ozawa T. Human platelet-derived transforming growth factor-β stimulates synthesis of glycosaminoglycans in cultured porcine aortic endothelial cells. Gerontology. 38:1992;36-42.
12. Kaji T, Hiraga S, Fujii N, Yamamoto C, Sakamoto M, Kozuka H, KIoizumi F. Plasmin-induced reduction of heparan sulfate in cultured vascular endothelial cell layer. Thromb Res. 74:1994;85-93.
13. Kaji T, Akai T, Hayashi T, Sakuragawa N. Thrombin decreases glycosaminoglycans content of endothelial cells in culture. Thromb Res 1991;61:375-84.
14. Kissane JM, Robins E. The fluorometric measurement of deoxyribonucleic acid in animal tissue with special reference to the central nervous system. J Biol Chem 1958;233:184-8.
15. Kinsella MG, Wight TN. Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration. J Cell Biol 1986;102:679-87.
16. Wasteson A. A method for the determination of the molecular weight and molecular weight distribution of chondroitin sulphate. J Chromatogr 59:87-97.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
18. Izzo RV, Cohen IR, Grassel S, Murdoch AD. The biology of perlecan: The multifaceted heparan sulfate proteoglycan of basement membranes and pericellular matrices. Biochem J 1994;302:625-39.
19. Mertens G, Cassiman JJ, Van Den Berghe H, Vermylen J, David G. Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. J Biol Chem 1992;267:20435-43.
20. Kojima T, Leone CW, Marchildon GA, Marcum JA, Rosenberg RD. Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells. J Biol Chem 1992;267:4859-69.
21. Vu T-KH, Hung D, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;64:1057-68.
22. Maruyama Y, Maruyama I, Soejima Y. Thrombin receptor agonist peptide decreases thrombomodulin activity in cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun 1994;199:1262-9.
23. Peracchia F, Tamburro A, Zanni M, Rotillio D. Effects of thrombin and thrombin peptide activating receptor (SFLLRN) on proteoglycan synthesis and distribution in human endothelial cells. Biochem Biophys Res Commun 1994;205:1625-31.
24. Fujii N, Kaji T, Yamamoto C, Fujiwara Y, Koizumi F. Phorbol 12-myristate 13-acetate stimulates the release of glycosaminoglycans from cultured vascular endothelial cells: Possible involvement of protein kinase C activation. Thromb Res 1996;82:379-87.
25. Gospodarowicz D, Brown KD, Birdwell CR, Zetter BR. Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin. J Cell Biol 1978;77:774-88.
26. Revtyak GE, Johnson AR, Campbell WB. Prostaglandin synthesis in bovine coronary endothelial cells: comparison with other commonly studied endothelial cells. Thromb Res 1987;48:671-83.
27. Aviezer D, Hecht D, Safran M, Eisinger M, David D, Yayon A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiognesis. Cell 1994;79:1005-13.
28. Aviezer D, Levy E, Safran M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A. Differential structural requirements of heparin and heparan sulfate proteoglycans that promotes binding of basic fibroblast growth factor to its receptor. J Biol Chem 1994;269:114-21.
29. Mali M, Elenius K, Miettinen HM, Jakanen M. Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1. J Biol Chem 1993;268:24215-22.
30. Scweigerer L, Newfeld DG, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987;325:257-9.
31. Gajdusek CM, Carbon S. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium. J Cell Physiol 1989;139:570-9.
32. Herbert JM, Dupuy E, Laplace MC, Zini JM, Bar-Shavit R, Tobelem G. Thrombin induces endothelial cell growth via both proteolytic and a non-proteolytic pathway. Biochem J 1994;303:227-31.
33. Kaji T, Miyamoto A, Yamamoto C, Fujiwara Y, Koizumi F Regulation by basic fibroblast growth factor of heparan sulfate proteoglycan production in vascular endothelial cells in culture. J Vasc Res. 33(Suppl 1):1977;45.